Safe Orthopaedics has announced the launch of a bone substitute for its Walnut cage for cervical surgeries in Europe.
This device, developed in conjunction with a specialist in synthetic bone substitutes, aims to promote bone growth and thus to make vertebral fusion safer.
In parallel, the SteriSpineCC range (Walnut cage and associated single-use ancillary) has also received 510(k) marketing approval from the US Food and Drug Administration (FDA). Although it is not commercialised in the United States, the company reports that this technology will gain more rapid approval in certain countries such as in Latin America and the Asia-Pacific region.
